Structural and functional left ventricular remodeling in heart failure with cardiac resynchronization therapy

Hind Rahmouni, Ted Plappert, Martin St John Sutton

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Congestive heart failure (CHF) is a clinical symptom complex characterized by fatigue, dyspnea, reduced exercise tolerance, lower extremity and pulmonary edema associated with abnormal handling of sodium by the kidney. There are an estimated 25-30 million patients with heart failure worldwide. Heart failure may occur at any age, but has a predilection for the elderly, occurring in 6-10% of subjects over the age of 65 years. The prevalence of CHF increases with advancing age, and as the population ages, the management of heart failure will attain epidemic proportions. Currently, CHF is the most common hospital discharge diagnosis in patients aged over 65 years, and the costs for this diagnostic-related group (DRG) in the USA alone have already exceeded $28 billion per year. failure was initially believed to be a relatively benign condition, but the annual mortality from diastolic heart failure ranges between 5% and 15% and the readmission rate for new-onset heart failure approaches 50% within the first 6 months.1-4 The remaining 50-70% of patients present with systolic heart failure, and are clinically indistinguishable from patients with diastolic heart failure. It is important to identify patients with systolic heart failure, as they are eligible for additional therapeutic options such as cardiac resynchronization therapy (CRT), which has never been tested in patients with primary diastolic heart failure.

Original languageEnglish (US)
Title of host publicationCardiac Resynchronization Therapy
PublisherCRC Press
Pages71-84
Number of pages14
ISBN (Electronic)9780203089965
ISBN (Print)9781841846378
StatePublished - Jan 1 2007
Externally publishedYes

Fingerprint

Cardiac Resynchronization Therapy
Ventricular Remodeling
Heart Failure
Diastolic Heart Failure
Systolic Heart Failure
Exercise Tolerance
Diagnosis-Related Groups
Pulmonary Edema
Dyspnea
Fatigue
Lower Extremity
Sodium
Kidney
Costs and Cost Analysis
Mortality
Population

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Rahmouni, H., Plappert, T., & St John Sutton, M. (2007). Structural and functional left ventricular remodeling in heart failure with cardiac resynchronization therapy. In Cardiac Resynchronization Therapy (pp. 71-84). CRC Press.

Structural and functional left ventricular remodeling in heart failure with cardiac resynchronization therapy. / Rahmouni, Hind; Plappert, Ted; St John Sutton, Martin.

Cardiac Resynchronization Therapy. CRC Press, 2007. p. 71-84.

Research output: Chapter in Book/Report/Conference proceedingChapter

Rahmouni, H, Plappert, T & St John Sutton, M 2007, Structural and functional left ventricular remodeling in heart failure with cardiac resynchronization therapy. in Cardiac Resynchronization Therapy. CRC Press, pp. 71-84.
Rahmouni H, Plappert T, St John Sutton M. Structural and functional left ventricular remodeling in heart failure with cardiac resynchronization therapy. In Cardiac Resynchronization Therapy. CRC Press. 2007. p. 71-84
Rahmouni, Hind ; Plappert, Ted ; St John Sutton, Martin. / Structural and functional left ventricular remodeling in heart failure with cardiac resynchronization therapy. Cardiac Resynchronization Therapy. CRC Press, 2007. pp. 71-84
@inbook{adb408effaba4320860f773b3029e4c2,
title = "Structural and functional left ventricular remodeling in heart failure with cardiac resynchronization therapy",
abstract = "Congestive heart failure (CHF) is a clinical symptom complex characterized by fatigue, dyspnea, reduced exercise tolerance, lower extremity and pulmonary edema associated with abnormal handling of sodium by the kidney. There are an estimated 25-30 million patients with heart failure worldwide. Heart failure may occur at any age, but has a predilection for the elderly, occurring in 6-10{\%} of subjects over the age of 65 years. The prevalence of CHF increases with advancing age, and as the population ages, the management of heart failure will attain epidemic proportions. Currently, CHF is the most common hospital discharge diagnosis in patients aged over 65 years, and the costs for this diagnostic-related group (DRG) in the USA alone have already exceeded $28 billion per year. failure was initially believed to be a relatively benign condition, but the annual mortality from diastolic heart failure ranges between 5{\%} and 15{\%} and the readmission rate for new-onset heart failure approaches 50{\%} within the first 6 months.1-4 The remaining 50-70{\%} of patients present with systolic heart failure, and are clinically indistinguishable from patients with diastolic heart failure. It is important to identify patients with systolic heart failure, as they are eligible for additional therapeutic options such as cardiac resynchronization therapy (CRT), which has never been tested in patients with primary diastolic heart failure.",
author = "Hind Rahmouni and Ted Plappert and {St John Sutton}, Martin",
year = "2007",
month = "1",
day = "1",
language = "English (US)",
isbn = "9781841846378",
pages = "71--84",
booktitle = "Cardiac Resynchronization Therapy",
publisher = "CRC Press",

}

TY - CHAP

T1 - Structural and functional left ventricular remodeling in heart failure with cardiac resynchronization therapy

AU - Rahmouni, Hind

AU - Plappert, Ted

AU - St John Sutton, Martin

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Congestive heart failure (CHF) is a clinical symptom complex characterized by fatigue, dyspnea, reduced exercise tolerance, lower extremity and pulmonary edema associated with abnormal handling of sodium by the kidney. There are an estimated 25-30 million patients with heart failure worldwide. Heart failure may occur at any age, but has a predilection for the elderly, occurring in 6-10% of subjects over the age of 65 years. The prevalence of CHF increases with advancing age, and as the population ages, the management of heart failure will attain epidemic proportions. Currently, CHF is the most common hospital discharge diagnosis in patients aged over 65 years, and the costs for this diagnostic-related group (DRG) in the USA alone have already exceeded $28 billion per year. failure was initially believed to be a relatively benign condition, but the annual mortality from diastolic heart failure ranges between 5% and 15% and the readmission rate for new-onset heart failure approaches 50% within the first 6 months.1-4 The remaining 50-70% of patients present with systolic heart failure, and are clinically indistinguishable from patients with diastolic heart failure. It is important to identify patients with systolic heart failure, as they are eligible for additional therapeutic options such as cardiac resynchronization therapy (CRT), which has never been tested in patients with primary diastolic heart failure.

AB - Congestive heart failure (CHF) is a clinical symptom complex characterized by fatigue, dyspnea, reduced exercise tolerance, lower extremity and pulmonary edema associated with abnormal handling of sodium by the kidney. There are an estimated 25-30 million patients with heart failure worldwide. Heart failure may occur at any age, but has a predilection for the elderly, occurring in 6-10% of subjects over the age of 65 years. The prevalence of CHF increases with advancing age, and as the population ages, the management of heart failure will attain epidemic proportions. Currently, CHF is the most common hospital discharge diagnosis in patients aged over 65 years, and the costs for this diagnostic-related group (DRG) in the USA alone have already exceeded $28 billion per year. failure was initially believed to be a relatively benign condition, but the annual mortality from diastolic heart failure ranges between 5% and 15% and the readmission rate for new-onset heart failure approaches 50% within the first 6 months.1-4 The remaining 50-70% of patients present with systolic heart failure, and are clinically indistinguishable from patients with diastolic heart failure. It is important to identify patients with systolic heart failure, as they are eligible for additional therapeutic options such as cardiac resynchronization therapy (CRT), which has never been tested in patients with primary diastolic heart failure.

UR - http://www.scopus.com/inward/record.url?scp=59249101379&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59249101379&partnerID=8YFLogxK

M3 - Chapter

SN - 9781841846378

SP - 71

EP - 84

BT - Cardiac Resynchronization Therapy

PB - CRC Press

ER -